Spanish climate-tech startup Clevergy has raised €3.2 million to accelerate its international expansion after tripling its growth last year. The round was co-led by Racine², (managed by Serena and makesense) and Axon Partners Group, through its Next Technology Fund supported by Ventures EPM. The round was completed by Satgana, Wayra (Telefónica’s CVC), and Angels (JuanContinue reading “Axon Partners Group co-leads Clevergy’s €3.2 million funding round”
Author Archives: maraviflo_2023-Axon
Equinor Ventures, backed by Axon Partners Group, bets on Spanish technology firm Hysun and closes a €3 million round to boost green hydrogen
Spanish company Hysun, specialised in clean hydrogen production from solar energy, has closed a funding round of €3 million with the support of leading international and national investors.The transaction brings in new partners Equinor Ventures – the corporate venture capital arm of the international energy company Equinor, committed to long-term value creation in a low-carbonContinue reading “Equinor Ventures, backed by Axon Partners Group, bets on Spanish technology firm Hysun and closes a €3 million round to boost green hydrogen”
Technology with Impact 2025: Strategic Deep Tech Investment with Purpose
Beyond Returns: How Disruptive Technologies Are Solving Critical Global Challenges While much of today’s tech investment focuses on short-term gains, Axon Partners Group’s Technology with Impact 2025 report demonstrates that the most significant returns arise when breakthrough innovation aligns with urgent societal needs. Report description:This report highlights over 25 Axon portfolio companies that deliver bothContinue reading “Technology with Impact 2025: Strategic Deep Tech Investment with Purpose”
Article: 6G: Can it really shape the future of connectivity
Fifteen years ago, 4G was about how we connected with each other through smartphones. Five years ago, the hype surrounding 5G centred on the introduction of new use cases, driven by increased speed, very low latencies, and enhanced reliability. With 6G, the focal point of the next-gen promise appears to switch from connectivity to sovereigntyContinue reading “Article: 6G: Can it really shape the future of connectivity”
Otofarma makes the leap to Euronext and enters a new phase of expansion
Otofarma, an Italian company specialising in customised hearing solutions, will begin trading tomorrow on Euronext Growth Milan, following the successful completion of an institutional offering that attracted strong interest from European investors. The offering was aimed exclusively at institutional and professional investors, both domestic and international, and was structured as a capital increase that raisedContinue reading “Otofarma makes the leap to Euronext and enters a new phase of expansion”
The Spanish Government supports the development of transformative technology companies through investments in Axon and Big Sur Ventures funds
The Council of Ministers has authorised the Ministry for Digital Transformation and Public Service, through the Spanish Agency for Technological Transformation (SETT), to invest in the Spanish venture capital funds Axon Innovation Growth and Big Sur Ventures, with investments of €85 million and €40 million, respectively. The objective is to support startups and scale-ups whoseContinue reading “The Spanish Government supports the development of transformative technology companies through investments in Axon and Big Sur Ventures funds”
Post-quantum cryptography: the new era of cyber defence
Quantum computing is no longer a distant possibility; it’s an emerging reality. And with it comes a fundamental threat to the cryptographic systems that secure our digital lives. In this timely publication, we explore the rise of post-quantum cryptography (PQC), the proactive, quantum-resistant approach to safeguarding data in an uncertain future. From understanding the limitations ofContinue reading “Post-quantum cryptography: the new era of cyber defence”
Axon joins Bullnet and CDTI in supporting Bioherent to advance allergy diagnostics
Bioherent, a biotechnology startup specialising in the development of in vitro diagnostic devices based on photonic biosensors and nanotechnology, has announced the addition of Axon Partners Group as a new investment partner. Axon will co-invest alongside Bullnet Capital and CDTI-Innvierte, the company’s original investors. The joint investment from Axon, Bullnet and CDTI will enable BioherentContinue reading “Axon joins Bullnet and CDTI in supporting Bioherent to advance allergy diagnostics”
BM2Solar secures €2 million to scale solar storage solutions with backing from Axon and Inclimo
BM2Solar, a company specialising in integrated energy storage solutions for solar power plants, has successfully closed a €2 million Series A funding round. The round was led by Axon Partners Group through its Next Technology Ventures fund, a vehicle focused on the energy transition and backed by Ventures EPM, with participation from Inclimo Climate Tech.Continue reading “BM2Solar secures €2 million to scale solar storage solutions with backing from Axon and Inclimo”
Article: Closing the climate credibility gap
How digital companies can turn climate promises into measurable action As digital transformation continues to accelerate, so does its energy footprint. From cloud platforms and telecom infrastructure to artificial intelligence and data centres, the digital sector is a major contributor to global emissions, and yet, its climate performance remains largely unaccounted for. A new reportContinue reading “Article: Closing the climate credibility gap”
Axon to Attend AI for Good Global Summit 2025
We’re pleased to announce that Jorge Martinez, Partner at Axon Consulting, will represent Axon at the AI for Good Global Summit 2025, taking place from July 8–11 in Geneva, Switzerland. Organised by the International Telecommunication Union (ITU) in partnership with UN sister agencies and co-convened with the Government of Switzerland, the AI for Good Global Summit is the United Nations’ leading platform focused on harnessingContinue reading “Axon to Attend AI for Good Global Summit 2025 “
Spin-off from Pablo de Olavide University revolutionises biomedical research with a promising compound for Alzheimer’s and Parkinson’s treatment
Pablo de Olavide University (UPO) has reaffirmed its commitment to biomedical innovation through its spin-off, Olavide Neuron STX, S.L., which has recently completed a successful €1 million capital increase to accelerate the development of its promising compound ONESTX‑1. Founded in 2020 by three researchers from the university, Olavide Neuron STX is dedicated to developing novelContinue reading “Spin-off from Pablo de Olavide University revolutionises biomedical research with a promising compound for Alzheimer’s and Parkinson’s treatment”